These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3574140)

  • 1. Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis.
    Need AG; Chatterton BE; Walker CJ; Steurer TA; Horowitz M; Nordin BE
    Maturitas; 1986 Dec; 8(4):275-80. PubMed ID: 3574140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
    Need AG; Horowitz M; Bridges A; Morris HA; Nordin BE
    Arch Intern Med; 1989 Jan; 149(1):57-60. PubMed ID: 2912415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
    Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE
    Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG; Horowitz M; Walker CJ; Chatterton BE; Chapman IC; Nordin BE
    Bone; 1989; 10(1):3-6. PubMed ID: 2736154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral content, cortical thickness and fracture rate in osteoporotic women after withdrawal of treatment with nandrolone decanoate, 1-alpha hydroxyvitamin D3, or intermittent calcium infusions.
    Geusens P; Dequeker J; Verstraeten A; Nijs J; Van Holsbeeck M
    Maturitas; 1986 Dec; 8(4):281-9. PubMed ID: 3574141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
    Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE
    Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C; AgnusDei D; Gonnelli S; Nardi P
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
    Geusens P; Dequeker J
    Bone Miner; 1986 Sep; 1(4):347-57. PubMed ID: 3333018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C; Agnusdei D; Gonnelli S
    Minerva Endocrinol; 1989; 14(1):69-74. PubMed ID: 2659955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nandrolone decanoate for men with osteoporosis.
    Hamdy RC; Moore SW; Whalen KE; Landy C
    Am J Ther; 1998 Mar; 5(2):89-95. PubMed ID: 10099043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.
    Geusens P
    Clin Rheumatol; 1995 Sep; 14 Suppl 3():32-9. PubMed ID: 8846659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
    Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of anabolic steroids on osteoporosis].
    Adachi M; Takayanagi R
    Clin Calcium; 2008 Oct; 18(10):1451-9. PubMed ID: 18830042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
    Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
    J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG; Nordin BE; Chatterton BE
    Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.
    Adami S; Fossaluzza V; Rossini M; Bertoldo F; Gatti D; Zamberlan N; Lo Cascio V
    Bone Miner; 1991 Oct; 15(1):73-81. PubMed ID: 1747568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic steroids and osteoporosis.
    Dequeker J; Geusens P
    Acta Endocrinol Suppl (Copenh); 1985; 271():45-52. PubMed ID: 3865481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.